A sharp drop in US stock indices happened on Wednesday after Fed Chair Jerome Powell stated that it was too early to think about pausing rate hikes.
A sharp drop in US stock indices happened on Wednesday after Fed Chair Jerome Powell stated that it was too early to think about pausing rate hikes.
In early November, a thorough analysis of major market movements over the past month is underway. Arcane Research senior analyst Vetle Lunde was able to identify the direction in which the market is likely to move for the foreseeable future.
Amazon Inc. is postponing a hiring process in its advertising division. These actions point to cuts in the world's largest e-commerce platform’s spending due to the sales slowdown.
The U.S. dollar slipped against major currencies on Wednesday. Traders are concerned about the U.S. Federal Reserve's upcoming interest rate decision and it affects the exchange rate. The Fed is about to take measures that will give hints to future policy.
Bank of Canada Governor Tiff Macklem stated that he doesn’t exclude the possibility of another sharp rate hike for the purpose of fighting inflation. Inflation remains higher than its target level of 2%, even though it declined to 6.9% in recent times.
Bundesbank President Joachim Nagel outlined an ambitious 8.8 trillion euros balance sheet reduction plan. Nagel said the European Central Bank intends to cut a huge balance sheet from government bonds early next year.
This month the level of manufacturing activity in the Eurozone fell to its lowest point since May 2020. This suggested that the countries of Europe are approaching a recession.
Bank of Japan Governor Haruhiko Kuroda says that a change in monetary policy in Japan is possible, but in the future. For now, the Bank of Japan is sticking to its yield curve control (YCC) policy.
U.S. Johnson & Johnson inked a deal Tuesday to buy heart pump company Abiomed Inc for $16.6 billion in cash, according to Reuters, as the company seeks to boost its medical device business following a planned spin-off of its over-the-counter drugs unit next year.
On Thursday, analysts of BofA Securities published a note indicating that Apple's shares still have a neutral rating and the $160 price target. Investors announced that App Store revenues declined in comparison with the previous year.